Global Alzheimer's Disease (AD) Blood-based Detection Kits Market Growth 2024-2030

Global Alzheimer's Disease (AD) Blood-based Detection Kits Market Growth 2024-2030

Alzheimer's Disease (AD) blood-based detection kits are diagnostic tools designed to detect biomarkers associated with Alzheimer's disease in blood samples. These kits offer a non-invasive and potentially cost-effective method for early detection and monitoring of Alzheimer's disease. Several types of blood-based detection kits for Alzheimer's disease are being developed and studied, each targeting specific biomarkers or molecular signatures associated with the disease.

The global Alzheimer's Disease (AD) Blood-based Detection Kits market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “Alzheimer's Disease (AD) Blood-based Detection Kits Industry Forecast” looks at past sales and reviews total world Alzheimer's Disease (AD) Blood-based Detection Kits sales in 2023, providing a comprehensive analysis by region and market sector of projected Alzheimer's Disease (AD) Blood-based Detection Kits sales for 2024 through 2030. With Alzheimer's Disease (AD) Blood-based Detection Kits sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Alzheimer's Disease (AD) Blood-based Detection Kits industry.

This Insight Report provides a comprehensive analysis of the global Alzheimer's Disease (AD) Blood-based Detection Kits landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Alzheimer's Disease (AD) Blood-based Detection Kits portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Alzheimer's Disease (AD) Blood-based Detection Kits market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Alzheimer's Disease (AD) Blood-based Detection Kits and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Alzheimer's Disease (AD) Blood-based Detection Kits.

United States market for Alzheimer's Disease (AD) Blood-based Detection Kits is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Alzheimer's Disease (AD) Blood-based Detection Kits is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Alzheimer's Disease (AD) Blood-based Detection Kits is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Alzheimer's Disease (AD) Blood-based Detection Kits players cover Roche Diagnostics, Fujirebio, Quanterix, Revvity, People Bio, etc. In terms of revenue, the global two largest companies occupied for a share nearly

% in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Alzheimer's Disease (AD) Blood-based Detection Kits market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Amyloid Beta (Aβ) Detection Kits
Tau Protein Detection Kits
Others

Segmentation by Application:
Medical
Research

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Roche Diagnostics
Fujirebio
Quanterix
Revvity
People Bio
Easund Bio-tech and Pharmakea
MagQu
Solgent
Sysmex
Fujifilm
Immuno-Biological Laboratories
Shenzhen Anqun Bioengineering
Amoneta Diagnostics

Key Questions Addressed in this Report

What is the 10-year outlook for the global Alzheimer's Disease (AD) Blood-based Detection Kits market?

What factors are driving Alzheimer's Disease (AD) Blood-based Detection Kits market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Alzheimer's Disease (AD) Blood-based Detection Kits market opportunities vary by end market size?

How does Alzheimer's Disease (AD) Blood-based Detection Kits break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.